A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma
Noa Biran, Scott D. Rowley, David H. Vesole, Shijia Zhang, Michele L. Donato, Joshua Richter, Alan P. Skarbnik, Andrew Pecora, David S. Siegel
Dive into the research topics of 'A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma'. Together they form a unique fingerprint.